CDA and acute myeloid leukemia: We conducted this study in a cohort of Mexican pediatric patients with AML to investigate whether the CDA Single Nucleotide Polymorphism (SNP) A79C and the dCK SNPs C360G and C201T are implicated in clinical response and toxicity of this leukemia.